Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36b5c496f6aec894819ec2acaedb4203 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y114-99009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y101-01053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y114-15004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y118-01002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y106-02004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y114-15006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0071 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P33-00 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-85 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-04 |
filingDate |
1989-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2453014bce881790c9ece3fcec2614aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b95733504af849238d22d431653a078 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3096d6ad376bb9e89541ae899b493b0d |
publicationDate |
1996-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
PT-92543-B |
titleOfInvention |
PROCESS FOR MULTIPLE OXIDATION OF STEROIDS AND FOR THE OBTAINING OF CELLS BY GENETIC ENGINEERING TO BE USED IN THEIR REALIZATION |
abstract |
Genetically engineered host cells are provided which are able to carry out simultaneously oxidations of steroids, preferably the simultaneous introduction of the 17 alpha -hydroxyl and the C21-hydroxyl group. In particular the oxidation is carried out with cells into which DNA has been introduced which encodes for at least two proteins involved in the biological pathway of cholesterol to hydrocortisone. Suited host cells comprise species of Bacillus, Saccharomyces or Kluyveromyces. The new host cells are suited for biochemical oxidations of cholesterol, pregnenolone, progesterone and 17 alpha -hydroxy-progesterone, which are intermediates in said biological pathway. The host cells are also useful for the ultimate preparation of a multigenic system for the one-step conversion of cholesterol into hydrocortisone. |
priorityDate |
1988-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |